Survival for patients with newly diagnosed glioblastoma may be given a boost if initial results of dendritic vaccines using patients’ own cells hold up. But experts are skeptical.
Medscape Medical News
This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.